Surgical Outcomes and Costs in Using the Shenzhen HugeMed 6.3 French Flexible Ureteroscope

ConditionKidney Stones
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Kansas Medical Center

About this trial

Comprehensive comparative investigations between HugeMed HU30M 6.3 Fr f-URS and traditional approach f-URS devices in RIRS are lacking in an American population. The investigators aim to compare the outcomes of using the 6.3 Fr f-URS versus traditional approach (other f-URS present in our institution) to treat patients with stone burden ≤ 2.5 cm. The findings of this study will expand on the potential advantages and drawbacks of HU30M in enhancing surgical outcomes and patient safety in RIRS procedures. We hypothesize that the use of the HU30M will result in increased cost savings while providing similar stone free rates when compared to traditionally used f-URS devices.

Eligibility criteria

Qualifiers

Males or females ≥ 18 years of age

Patients with ureteral or kidney stones undergoing primary flexible ureteroscopy for retrograde intrarenal surgery

Total stone burden ≤ 2.5 cm

Disqualifiers

Undergoing bilateral stone treatment during the same procedure

Patients with known genitourinary anatomical abnormalities that would complicate the procedure as determined by the treating investigator

Uncorrected coagulopathy

Patients with urinary diversions

Trial design

Treatments tested in this trial

  • Ureteroscopy using the 6.3 Fr f-URS hugemed
  • Hugemed 6.3 Fr f-URS

Treatment groups

75 Participants
are divided into 1 treatment group

Sponsors and collaborators